“…Considering the coexistence of hIAPP and Aβ in the human brain and pancreas, ,− alongside the clinical overlaps between AD and T2D, , extensive studies have investigated the interplay between these peptides, encompassing coaggregation and cross-seeding phenomena. , hIAPP aggregates more rapidly than Aβ at equivalent concentrations, displaying significantly shorter lag phases in vitro . , Co-aggregation experiments reveal that a mixture of soluble Aβ and hIAPP exhibits a shorter aggregation lag phase than Aβ alone, albeit slightly longer than IAPP alone at the same total peptide concentrations . Fibrils formed by both Aβ and hIAPP can act as seeds, mutually promoting each other’s amyloid aggregation, though less efficiently than their self-seeding processes. , Computational simulations have extensively explored the molecular interactions underlying this cross-talk, including possible interactions between Aβ and hIAPP fibrils, ,− heterodimerization of Aβ and hIAPP, , and the coaggregation of amyloidogenic fragments from both peptides. , Notably, hotspot binding regions between Aβ and hIAPP have been identified in vitro and in silico , involving Aβ residues 11–21 and 30–42, and hIAPP residues 8–20 and 21–37. ,, Moreover, recent computational simulations have shown that a mixture of Aβ 16–22 and hIAPP 20–29 fragments can readily form β-barrel oligomers, prompting inquiries about whether full-length Aβ and hIAPP can also form similar β-barrel structures . Previous computational studies on Aβ and hIAPP coaggregation primarily focused on either the structures and dynamics of full-length heterodimers , or the co-oligomerization of multiple short fragments. , As we have shown previously, the structural dynamics of oligomers in amyloid aggregation is highly dependent on the oligomer size; − e.g., hIAPP 8–20 underwent α-helix to β-sheet transition only when the aggregates were at least hexamers .…”